Influenza A Virus Hemagglutinin-Neuraminidase-Receptor Balance: Preserving Virus Motility

被引:103
|
作者
de Vries, Erik [1 ]
Du, Wenjuan [1 ]
Guo, Hongbo [1 ]
de Haan, Cornelis A. M. [1 ]
机构
[1] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Virol Div, Yalelaan 1, NL-3584 CL Utrecht, Netherlands
关键词
SIALIC-ACID; STALK-LENGTH; BINDING SPECIFICITY; FUNCTIONAL BALANCE; AMINO-ACID; RESPIRATORY-TRACT; ANTIGENIC CHANGE; CELL TROPISM; H5N1; VIRUSES; EX-VIVO;
D O I
10.1016/j.tim.2019.08.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Influenza A viruses (IAVs) occasionally cross the species barrier and adapt to novel host species. This requires readjustment of the functional balance of the sialic add receptor-binding hemagglutinin (HA) and the receptor-destroying neuraminidase (NA) to the sialoglycan-receptor repertoire of the new host. Novel techniques have revealed mechanistic details of this HA-NA-receptor balance, emphasizing a previously underappreciated crucial role for NA in driving the motility of receptor-associated IAV particles. Motility enables virion penetration of the sialylated mucus layer as well as attachment to, and uptake into, underlying epithelial cells. As IAVs are essentially irreversibly bound in the absence of NA activity, the fine-tuning of the HA-NA-receptor balance rather than the binding avidity of IAV particles per se is an important factor in determining host species tropism.
引用
收藏
页码:57 / 67
页数:11
相关论文
共 50 条
  • [31] Biophysical Measurement of the Balance of Influenza A Hemagglutinin and Neuraminidase Activities
    Benton, Donald J.
    Martin, Stephen R.
    Wharton, Stephen A.
    McCauley, John W.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (10) : 6516 - 6521
  • [32] Functional balance between haemagglutinin and neuraminidase in influenza virus infections
    Wagner, R
    Matrosovich, M
    Klenk, HD
    REVIEWS IN MEDICAL VIROLOGY, 2002, 12 (03) : 159 - 166
  • [33] MATURATION OF INFLUENZA-VIRUS HEMAGGLUTININ AND NEURAMINIDASE POLYPEPTIDES IN INFECTED-CELLS
    SELIMOVA, LM
    AKISHPAEVA, OT
    ZAIDES, VM
    VOPROSY VIRUSOLOGII, 1981, (03) : 350 - 357
  • [34] INDEPENDENT AND DISPARATE EVOLUTION IN NATURE OF INFLUENZA-A VIRUS HEMAGGLUTININ AND NEURAMINIDASE GLYCOPROTEINS
    KILBOURNE, ED
    JOHANSSON, BE
    GRAJOWER, B
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (02) : 786 - 790
  • [35] The evolutionary potential of influenza A virus hemagglutinin is highly constrained by epistatic interactions with neuraminidase
    Liu, Tongyu
    Wang, Yiquan
    Tan, Timothy J. C.
    Wu, Nicholas C.
    Brooke, Christopher B.
    CELL HOST & MICROBE, 2022, 30 (10) : 1363 - +
  • [36] Drivers of recombinant soluble influenza A virus hemagglutinin and neuraminidase expression in mammalian cells
    van der Woude, Roosmarijn
    Turner, Hannah L.
    Tomris, Ilhan
    Bouwman, Kim M.
    Ward, Andrew B.
    de Vries, Robert P.
    PROTEIN SCIENCE, 2020, 29 (09) : 1975 - 1982
  • [37] Influenza virus hemagglutinin and neuraminidase glycoproteins stimulate the membrane association of the matrix protein
    Enami, M
    Enami, K
    JOURNAL OF VIROLOGY, 1996, 70 (10) : 6653 - 6657
  • [38] POLYPEPTIDES OF INFLUENZA VIRUS .3. IDENTIFICATION OF HEMAGGLUTININ, NEURAMINIDASE AND NUCLEOCAPSID PROTEINS
    HASLAM, EA
    HAMPSON, AW
    RADISKEVICS, I
    WHITE, DO
    VIROLOGY, 1970, 42 (03) : 566 - +
  • [39] Triplet entropy analysis of hemagglutinin and neuraminidase sequences measures influenza virus phylodynamics
    Gerhardt, Guenther J. L.
    Takeda, Agnes A. S.
    Andrighetti, Tahila
    Sartor, Ivaine T. S.
    Echeverrigaray, Sergio L.
    de Avila e Silva, Scheila
    dos Santos, Laurita
    Rybarczyk-Filho, Jose L.
    GENE, 2013, 528 (02) : 277 - 281
  • [40] Preventing Influenza A Virus Infection by Mixed Inhibition of Neuraminidase and Hemagglutinin by Divalent Inhibitors
    Wei, Xuan
    Du, Wenjuan
    Duca, Margherita
    Yu, Guangyun
    de Vries, Erik
    de Haan, Cornelis A. M.
    Pieters, Roland J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (10) : 7312 - 7323